Microsomal interactions and inhibition of lipid peroxidation by etoposide (VP-16, 213): implications for mode of action.
D000818:Animals; D003630:Daunorubicin / Q000494:pharmacology; D005047:Etoposide / Q000378:metabolism / Q000494:pharmacology*; D005609:Free Radicals; D008054:Lipid Peroxides / Q000378:metabolism*; D051379:Mice; D008862:Microsomes, Liver / Q000187:drug effects / Q000378:metabolism*; D009249:NADP / Q000378:metabolism; D010101:Oxygen Consumption / Q000187:drug effects; D011034:Podophyllotoxin / Q000031:analogs & derivatives*
D005609:Free Radicals; D008054:Lipid Peroxides; D009249:NADP; D005047:Etoposide; D011034:Podophyllotoxin; D003630:Daunorubicin